Although studies on asunercept function in GBM mainly suggest that it inhibits cell/tumor invasiveness and prolongs glioma-bearing mouse survival, the asunercept-targeted CD95/CD95L signaling pathway is also involved in cancer immune regulation [16,18]. Here, FAS is linked to glioblastoma.